Mark Sumeray
Signal active
Chief Medical Officer
Contact Information
Social
Primary Organization
Amolyt Pharma
Founded
2015
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical, Medical, Wellness
Bio
Mark Sumeray is the current Chief Medical Officer of Amolyt Pharma. He previously worked at Metys Pharmaceuticals as a Non Executive Director. Mark Sumeray attended UCL.
Location
Basel, Basel-Stadt, Switzerland, Europe
Jobs history
2
Amolyt Pharma
Chief Medical Officer
2022 - Current
Board Member
2022 - Current
Educations
2
University College London (UCL)
Medicine
Royal College of Surgeons
Surgery
Profile Resume
Mark Sumeray is the Chief Medical Officer at Amolyt Pharma, based in Switzerland, Europe. With a background in Biotechnology, Mark Sumeray has a rich history of leadership and innovation.Mark Sumeray studied MD Medicine at University College London (UCL). Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.